CoChat

The Immune Microenvironment of Malignant Pleural Mesothelioma: A Literature Review

Open access
Désage, Anne-Laure, Karpathiou, Georgia, Peoc’h, Michel, Froudarakis, Marios E. · 2021 · Cancers

The DOI matches its Crossref record; 158 of the 165 references it cites were found in a registry or an index.

Abstract

Malignant pleural mesothelioma (MPM) is a rare and aggressive tumour with a poor prognosis, associated with asbestos exposure. Nowadays, treatment is based on chemotherapy with a median overall survival of less than two years. This review highlights the main characteristics of the immune microenvironment in MPM with special emphasis on recent biological advances. The MPM microenvironment is highly infiltrated by tumour-associated macrophages, mainly M2-macrophages. In line with infiltration by M2-macrophages, which contribute to immune suppression, other effectors of innate immune response are deficient in MPM, such as dendritic cells or natural killer cells. On the other hand, tumour infiltrating lymphocytes (TILs) are also found in MPM, but CD4+ and CD8+ TILs might have decreased cytotoxic effects through T-regulators and high expression of immune checkpoints. Taken together, the immune microenvironment is particularly heterogeneous and can be considered as mainly immunotolerant or immunosuppressive. Therefore, identifying molecular vulnerabilities is particularly relevant to the improvement of patient outcomes and the assessment of promising treatment approaches.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cancers13133205

Cites

158 of 158 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 An epithelioid malignant mesothelioma showing large tumour cells (yellow arrow) intermixed with smaller lymphocytes (blue arrow) (X400).
Figure 1 An epithelioid malignant mesothelioma showing large tumour cells (yellow arrow) intermixed with smaller lymphocytes (blue arrow) (X400).CC BY · PubMed Central
Figure 2 The same focus of epithelioid mesothelioma as that shown in Figure 1, stained for CD163, revealing numerous macrophages (X400).
Figure 2 The same focus of epithelioid mesothelioma as that shown in Figure 1, stained for CD163, revealing numerous macrophages (X400).CC BY · PubMed Central
Figure 3 Another case of epithelioid mesothelioma stained for CD163 showing much lower numbers of positive macrophages (X400).
Figure 3 Another case of epithelioid mesothelioma stained for CD163 showing much lower numbers of positive macrophages (X400).CC BY · PubMed Central
Figure 4 Important infiltrate of lymphocytes (triangle) surrounding tumour (ovals) in the same case of malignant mesothelioma shown in Figure 3 (X40).
Figure 4 Important infiltrate of lymphocytes (triangle) surrounding tumour (ovals) in the same case of malignant mesothelioma shown in Figure 3 (X40).CC BY · PubMed Central
Figure 5 Heavy CD8 intratumoral infiltrate in the malignant mesothelioma case shown in Figure 1 (X400).
Figure 5 Heavy CD8 intratumoral infiltrate in the malignant mesothelioma case shown in Figure 1 (X400).CC BY · PubMed Central
Figure 6 In comparison to the previous case, this malignant mesothelioma harbors few CD8+ lymphocytes (arrow), mostly in the peritumoral compartment (X400).
Figure 6 In comparison to the previous case, this malignant mesothelioma harbors few CD8+ lymphocytes (arrow), mostly in the peritumoral compartment (X400).CC BY · PubMed Central
Figure 7 Abundant PD-L1 expression in this case of malignant mesothelioma (X400). Most stained cells probably correspond to immune cells (smaller size, less atypia; yellow arrow), while most tumour cells show no membranous staining (red arrow). However, further markers in conjunction to PD-L1 would be necessary to better characterize the two cell populations.
Figure 7 Abundant PD-L1 expression in this case of malignant mesothelioma (X400). Most stained cells probably correspond to immune cells (smaller size, less atypia; yellow arrow), while most tumour cells show no membranous staining (red arrow). However, further markers in conjunction to PD-L1 would be necessary to better characterize the two cell populations.CC BY · PubMed Central
Figure 8 PD-L1 is not expressed by tumour cells (upper part of the image, yellow circle) in this malignant mesothelioma, but there are a few PD-L1+ immune cells in the neighbouring stroma (lower part, red circle).
Figure 8 PD-L1 is not expressed by tumour cells (upper part of the image, yellow circle) in this malignant mesothelioma, but there are a few PD-L1+ immune cells in the neighbouring stroma (lower part, red circle).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 158 references

Cited by

See all 34

Metadata

Authors
Désage, A.-L., Karpathiou, G., Peoc’h, M., & Froudarakis, M. E.
Affiliations
  • Centre Hospitalier Universitaire de Saint-Étienne (FR)
  • Pathology, North Hospital, University Hospital of Saint-Etienne, 42055 Saint-Etienne, France
  • Department of Pulmonology and Thoracic Oncology, North Hospital, University Hospital of Saint-Etienne, 42055 Saint-Etienne, France
Venue
Cancers
Publisher
MDPI AG
Published
2021-06-26
Volume
13
Issue
13
Pages
3205
ISSN
2072-6694 (ISSN-L)
OpenAlex
W3175991011
Cited by
34
References
165
Citations by year
2026: 6 · 2025: 7 · 2024: 3 · 2023: 9 · 2022: 7 · 2021: 2
FWCI
0.84
Type
journal article
Language
en
Open access
Locations
  • Cancers (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords
malignant pleural mesothelioma, tumor immune microenvironment, tumour-associated macrophages, M2 macrophages, immunosuppression, dendritic cells, natural killer cells, tumor-infiltrating lymphocytes, regulatory T cells, immune checkpoint, asbestos exposure, immunotherapy targets

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Immune Microenvironment of Malignant Pleural Mesothelioma: A Literature Review. https://app.cochat.ai/papers/10.3390/cancers13133205
The paper
Désage, A.-L., Karpathiou, G., Peoc’h, M., & Froudarakis, M. E. (2021). The Immune Microenvironment of Malignant Pleural Mesothelioma: A Literature Review. Cancers. https://doi.org/10.3390/cancers13133205

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.